Market Value to Book Value Ratio: Zimmer (ZBH)
Pricing pressure on implants and staffing shortages in clinics are creating headwinds for Zimmer Biomet Holdings (ZBH). The company is countering this through IT sector partnerships and the acquisition of surgical software. The market cap to book value ratio trend visualizes the market premium over assets, where the value 1.48 reflects the metric's balance. Outlooks rely on the implementation of the ROSA system and the development of AI analytics in orthopedics.
Summary analytical data breakdowns for zimmerbiomet.com (ZBH)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt obligations and liquidity statistics:
Total Debt to Capital Zimmer Biomet Holdings|ZBH - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Zimmer Biomet|ZBH - Company Aggregate Debts|Debt to Book Capitalization Ratio Zimmer Biomet Corp|ZBH - Company Long-Term Debt|Company Short-Term Debts Zimmer Biomet|Quick Liquidity Indicator zimmerbiomet.com
- earnings and valuation multiples indicators:
Initial company analysis:Zimmer Biomet Holdings
Zimmer Biomet Holdings (ZBH) is facing pressure on implant pricing and a shortage of medical alloys, which directly impacts the value of its net assets. The current price-to-book ratio at 1.48 demonstrates a market premium over book value, allowing investors to assess resource capitalization efficiency and volatility risks during a market contraction.
Direct competitors
Boston Scientific (BSX) - Market Value to Book Value Ratio|EW - Market Capitalization to Book Value|Market Value to Book Value Ratio ResMed|Insulet Corp - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio COO|ALGN - Market-to-Book Ratio|Market Capitalization to Book Value Ratio GMED (Globus Medical, Inc.)|TMDX - Market Cap to Net Assets Ratio|Alphatec - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value CryoLife AORT|ENOV: Market Capitalization to Book Value Ratio|Integra LifeSciences Inc. (IART) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Establishment Labs|Market Value to Book Value Ratio BBNX|Market Capitalization to Book Value Ratio IRMD|Market Capitalization to Book Value Embecta Corp|Tandem Diabetes - Market Cap to Net Assets Ratio|AXGN (Axogen Surgical) - Market Capitalization to Net Assets|SI-BONE, Inc. - Market Capitalization to Book Value Ratio|Market-to-Book Ratio orthofix.com|BVS: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio KIDS|Market Cap to Net Assets Ratio TMCI|SRTA: Market Value to Book Value|Market Value to Book Value Ratio Carlsmed Inc (CARL)|Market Cap to Net Assets Ratio rxsight.com RXST|Market Capitalization to Book Value Ratio CLPT (ClearPoint Neuro)|Stereotaxis Inc (STXS) - Market-to-Book Ratio|NeuroStar - Market Capitalization to Book Value Ratio|SGHT (Sight Sciences Inc) - Capitalization to Book Value Ratio|OBIO: Market Capitalization to Book Value Ratio|ANIK - Market Capitalization to Book Value|NSPR (InspireMD) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Jin Medical International Ltd (ZJYL)|Market Capitalization to Book Value Ratio VANI|Market Capitalization to Book Value Ratio xtantmedical.com (XTNT)|Market Value to Book Value Ratio NeuroOne Medical Technologies NMTC|Modular Medical Inc - Market Value to Book Value Ratio|MYO: Market Cap to Net Assets Ratio|Market Value to Book Value COCH (Envoy Medical Inc.)|VVOS: Market Capitalization to Book Value Ratio|Market-to-Book Ratio enVVeno Corp (NVNO)|Market Value to Book Value Ratio Sintx Technologies Inc|TNON - Market Value to Equity Ratio|Market Cap to Net Assets Ratio LFWD (Lifeward)|Market Capitalization to Book Value Ratio autonomix.com (AMIX)|Market Capitalization to Book Value Ratio IVF (INVO Bioscience, Inc.)|Market Capitalization to Book Value Bone Biologics Inc (BBLG)|AXNX - Market Value to Book Value Ratio|Market Capitalization to Net Assets BIOL|dynatronics.com (DYNT) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Paragon 28|INVO (INVO Bioscience Inc.) - Market Capitalization to Book Value Ratio